|
GB8823869D0
(en)
|
1988-10-12 |
1988-11-16 |
Medical Res Council |
Production of antibodies
|
|
US6329508B1
(en)
|
1989-09-07 |
2001-12-11 |
Alkermes, Inc. |
Transferrin receptor reactive chimeric antibodies
|
|
US6056957A
(en)
*
|
1994-08-04 |
2000-05-02 |
Schering Corporation |
Humanized monoclonal antibodies against human interleukin-5
|
|
US6787637B1
(en)
|
1999-05-28 |
2004-09-07 |
Neuralab Limited |
N-Terminal amyloid-β antibodies
|
|
US6596541B2
(en)
|
2000-10-31 |
2003-07-22 |
Regeneron Pharmaceuticals, Inc. |
Methods of modifying eukaryotic cells
|
|
JP2006526414A
(ja)
|
2003-06-02 |
2006-11-24 |
アレクシオン ファーマシューティカルズ， インコーポレイテッド |
脱免疫化抗ｃｄ３抗体
|
|
AR045563A1
(es)
|
2003-09-10 |
2005-11-02 |
Warner Lambert Co |
Anticuerpos dirigidos a m-csf
|
|
JP4294082B2
(ja)
|
2006-03-23 |
2009-07-08 |
協和発酵キリン株式会社 |
ヒトトロンボポエチン受容体に対するアゴニスト抗体
|
|
US7608693B2
(en)
*
|
2006-10-02 |
2009-10-27 |
Regeneron Pharmaceuticals, Inc. |
High affinity human antibodies to human IL-4 receptor
|
|
WO2009091240A1
(en)
|
2008-01-15 |
2009-07-23 |
Stichting Sanquin Bloedvoorziening |
Method and kits for detecting antibodies against therapeutic antibodies
|
|
AU2009303318B2
(en)
*
|
2008-10-10 |
2016-06-30 |
Aptevo Research And Development Llc |
TCR complex immunotherapeutics
|
|
CA2741114A1
(en)
|
2008-10-24 |
2010-04-29 |
Cornelis Lammert Verweij |
Biomarkers for predicting the development of chronic autoimmune diseases
|
|
DE102008061522A1
(de)
|
2008-12-10 |
2010-06-17 |
Biontech Ag |
Verwendung von Flt3-Ligand zur Verstärkung von Immunreaktionen bei RNA-Immunisierung
|
|
WO2010122148A1
(en)
|
2009-04-24 |
2010-10-28 |
Boehringer Ingelheim International Gmbh |
An improved antibody domain and antibody fragments and antibodies based thereon
|
|
MY192182A
(en)
*
|
2009-06-26 |
2022-08-04 |
Regeneron Pharma |
Readily isolated bispecific antibodies with native immunoglobulin format
|
|
WO2011074965A1
(en)
|
2009-12-17 |
2011-06-23 |
Stichting Sanquin Bloedvoorziening |
Methods and means for counteracting an activity of an fc domain
|
|
WO2012166588A2
(en)
|
2011-06-01 |
2012-12-06 |
Morehouse School Of Medicine |
Chemokine-immunoglobulin fusion polypeptides, compositions, method of making and use thereof
|
|
PE20141522A1
(es)
|
2011-08-17 |
2014-11-17 |
Glaxo Group Ltd |
Proteinas y peptidos modificados
|
|
HK1220465A1
(zh)
*
|
2013-03-06 |
2017-05-05 |
Merrimack Pharmaceuticals, Inc. |
抗c-met串联fc双特异性抗体
|
|
TWI633891B
(zh)
*
|
2013-06-04 |
2018-09-01 |
再生元醫藥公司 |
藉由投與ｉｌ－４ｒ抑制劑以治療過敏及增強過敏原－特異之免疫療法的方法
|
|
CN112552401B
(zh)
|
2013-09-13 |
2023-08-25 |
广州百济神州生物制药有限公司 |
抗pd1抗体及其作为治疗剂与诊断剂的用途
|
|
IL315136A
(en)
*
|
2014-02-21 |
2024-10-01 |
Sanofi Biotechnology |
Methods for treating or preventing asthma by administering an il-4rantagonist
|
|
US9951141B2
(en)
*
|
2014-06-02 |
2018-04-24 |
Regeneron Pharmaceuticals, Inc. |
Antibody-drug conjugates, their preparation and their therapeutic use
|
|
EP3200823B1
(en)
|
2014-10-02 |
2022-11-23 |
City of Hope |
Multivalent meditopes, meditope-binding antibodies and uses thereof
|
|
MX2017005156A
(es)
*
|
2014-11-05 |
2017-08-08 |
Hoffmann La Roche |
Metodo para determinacion de anticuerpos de anti-farmaco contra anticuerpo de farmaco humano o humanizado de funcion efectora suprimida.
|
|
AU2015346150B2
(en)
|
2014-11-14 |
2021-08-19 |
Regeneron Pharmaceuticals, Inc. |
Methods for treating chronic sinusitis with nasal polyps by administering an IL-4R antagonist
|
|
US9139653B1
(en)
|
2015-04-30 |
2015-09-22 |
Kymab Limited |
Anti-human OX40L antibodies and methods of treatment
|
|
WO2017072210A1
(en)
*
|
2015-10-29 |
2017-05-04 |
F. Hoffmann-La Roche Ag |
Anti-variant fc-region antibodies and methods of use
|
|
AU2016344133A1
(en)
|
2015-10-30 |
2018-05-17 |
Genentech, Inc. |
Anti-Factor D antibody formulations
|
|
MX2019002867A
(es)
|
2016-09-19 |
2019-11-12 |
Celgene Corp |
Metodos de tratamiento de trastornos inmunologicos usando proteinas de union a pd-1.
|
|
TW201829463A
(zh)
|
2016-11-18 |
2018-08-16 |
瑞士商赫孚孟拉羅股份公司 |
抗hla-g抗體及其用途
|
|
EP3713966A1
(en)
|
2017-11-22 |
2020-09-30 |
Vacara AB |
Antibodies to citrullinated proteins
|
|
AR115730A1
(es)
|
2018-07-10 |
2021-02-17 |
Regeneron Pharma |
Modificación de moléculas de unión para minimizar interacciones pre-existentes
|
|
WO2020246891A1
(en)
|
2019-06-07 |
2020-12-10 |
Sanquin Innovatie B.V. |
Methods and compounds for typing rheumatoid factors
|